Cath Lab

Volcano Corp. announced U.S. Food and Drug Administration (FDA) clearance of its proprietary instant wave-Free Ratio or iFR Modality.

April 16, 2014 — Abbott announced it has completed enrollment of three clinical trials to support approvals of the company's Absorb bioresorbable vascular scaffold (BVS) in the United States, Japan and China. Combined, the U.S., Japan and China ac...

Edwards lawsuit over Corevalve

The U.S. District Court for the District of Delaware granted a preliminary injunction limiting the sale of Medtronic's CoreValve transcatheter aortic valve replacement (TAVR) system in the United States. The court ordered the injunction April 10....

Cardinal Health announced an agreement to acquire privately held AccessClosure Inc. for $320 million. 

FDA Clearnace Volcano Corp. iFR Modality FFR Catheter Cath Lab
Volcano Corp. announced U.S. Food and Drug Administration (FDA) clearance of its proprietary instant wave-Free Ratio or iFR Modality.
April 21, 2014 — Cardiologists and cancer experts at the Mount Sinai Hospital in Manhattan have joined forces to establish its first cardio-oncology...
Treatment options for high-risk heart patients with severely calcified coronary artery disease (CAD) have been limited for more than 20 years. Now, Robert Wood...
Tendyne Holdings Inc. has secured $25 million in an oversubscribed Series C financing led by Apple Tree Partners, along with Boulle Group members and other...
FDA Clearnace Volcano Corp. iFR Modality FFR Catheter Cath Lab
Volcano Corp.'s  iFR Modality is a physiologic measurement performed using the same pressure wires and equipment utilized in cath
The app-driven Seer 1000 Holter recorder from GE Healthcare utilizes new technology to simplify Holter monitor management. The Seer 1000 is...
At the 2014 annual scientific session of the American College of Cardiology (ACC), GE Healthcare introduced a new version of its Muse ECG (...
The Acist|RXi Rapid Exchange FFR system is the world's first rapid exchange FFR system. This device features new technology designed...

Articles

FDA Clearnace Volcano Corp. iFR Modality FFR Catheter Cath Lab
Volcano Corp. announced U.S. Food and Drug Administration (FDA) clearance of its proprietary instant wave-Free Ratio or iFR Modality.
April 16, 2014 — Abbott announced it has completed enrollment of three clinical trials to support approvals of the company's Absorb bioresorbable vascular...
Corevalve beats surgery, ACC 2014, TAVR vs surgery, Edwards lawsuit
The U.S. District Court for the District of Delaware granted a preliminary injunction limiting the sale of Medtronic's CoreValve transcatheter aortic valve...
SCAI ACC.14 Choosing Wisely Campaign Tests Treatments to Avoid Cath Lab
The Society for Cardiovascular Angiography & Interventions (SCAI) issued a list of five specific, evidence-based recommendations that should be avoided in...

Video Center

By Dave Fornell The biggest news item from the American College of Cardiology (ACC) 63rd Annual...
2 weeks 14 hours ago
By Dave Fornell, DAIC editor Data from several cutting-edge device clinical trials will be...
4 weeks 15 hours ago
By Dave Fornell, editor I have watched a trend in medical technology grow from a small ripple a...
5 weeks 10 hours ago
The webinar will focus on implementation of different strategies to help clinicians reduce radiation exposure during interventional cardiology procedures, both for patient and operators. It will...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve image quality, lesion detection and...
CVIS, cardiovascular information system
This webinar reviews multi-ology, multi-site, vendor neutral solutions that transform rigid departmental information silos into fluid, consolidated, information sharing systems. It discusses how to...